Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/S2215-0366(19)30045-8
Publication URI: http://dx.doi.org/10.1016/S2215-0366(19)30045-8
Type: Journal Article/Review
Parent Publication: The Lancet Psychiatry
Issue: 4